Lamotrigine Tablet, Film Coated, Extended Release
Product Images NDC 70518-4442

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 70518-4442). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100 mg Tab (100mg Picture)

Image shows a solid round tablet imprinted with 'Y33'. This round tablet is a lamotrigine extended-release 50 mg film-coated tablet available by REMEDYREPACK INC.*

FDA Label Image

200 mg Tab (200mg Picture)

The image shows the imprint 'Y34' on a round, film-coated extended-release tablet. This imprint is associated with lamotrigine 50 mg tablets. The product is manufactured by RemedyRepack Inc. and is for oral administration.*

FDA Label Image

250 mg Tab (250mg Picture)

lamotrigine 50 mg extended-release film-coated tablet with the imprint 'Y35'. The oval-shaped tablet is white, designed for oral use, and labeled by REMEDYREPACK INC.*

FDA Label Image

25 mg Tab (25mg Picture)

Lamotrigine extended-release 50 mg film-coated tablet marked with imprint 'Y31'. Oral tablet manufactured by RemedyRepack Inc., NDC 70518-4442.*

FDA Label Image

300 mg Tab (300mg Picture)

The image shows an oval-shaped, white film-coated extended-release tablet with the imprint "Y36". This corresponds to lamotrigine extended-release 50 mg, an oral prescription medication labeled by REMEDYREPACK INC.*

FDA Label Image

50 mg Tab (50mg Picture)

Tablet imprint showing the code 'Y32' on one side. This is a film-coated, extended-release lamotrigine 50 mg oral tablet, labeled by RemedyRepack Inc., NDC 70518-4442.*

FDA Label Image

Remedy_label (Remedy Label)

The image shows a label for Lamotrigine extended-release tablets, 50 mg strength, in a quantity of 30 tablets. The label indicates the product is round, green, and identified as Y32. It includes repackaging information by RemedyRepack Inc., Indiana, PA, and manufacturing details for Camber Pharma, Inc. The label advises storage at 20-25°C with permitted excursions.*

FDA Label Image

Figure 1. Proportion Of Patients By Responder Rate For Lamotrigine And Placebo Group (primary Generalized Tonic-clonic Seizures Study) (Figure 1)

A responder rate cumulative distribution graph comparing lamotrigine extended-release tablets (solid line, N=70) versus placebo (dashed line, N=73). The vertical axis shows responder rate (% equal or greater improvement to worsening), and the horizontal axis shows the percent of patients from 0 to 100. The graph illustrates the distribution of patient responses to treatment and placebo.*

FDA Label Image

Figure 2. Proportion Of Patients By Responder Rate For Lamotrigine And Placebo Group (partial-onset Seizure Study) (Figure 2)

A responder rate chart comparing lamotrigine extended-release to placebo, showing responder rate (equal or greater improvement versus worsening) on the vertical axis and percent of patients on the horizontal axis. Two curves represent treatment groups: a solid line for lamotrigine and a dashed line for placebo, depicting differences in patient response rates between the groups.*

FDA Label Image

Chemical Structure (Graphic 01)

Chemical structure of lamotrigine, depicting its molecular formula with chlorine atoms, amine groups, and triazine ring clearly illustrated. This structure corresponds to the active ingredient lamotrigine in the extended-release tablet by RemedyRepack Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.